正大天晴药业集团股份有限公司

Chinese pharmaceutical group headquartered in Lianyungang, Jiangsu and a core subsidiary of the Hong Kong listed Sino Biopharmaceutical. Develops, manufactures and markets medicines concentrated in oncology, hepatology, respiratory disease and surgery and analgesia, with products including anlotinib, and runs large research operations in Nanjing, Lianyungang, Beijing and Shanghai alongside its own active ingredient and formulation manufacturing.